Imperagen

Imperagen

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

Total raised
$6.7M
tracked to date
Latest round
Seed
May 21, 2026
Known investors
3
led by PXN Ventures
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund DeepTech startups in United Kingdom.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 UK Funding Report

Read the Q2 2026 UK report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 UK Funding Report</a>

Funding history

  1. 1
    $6.7MSeedMay 21, 2026

    Led by PXN Ventures

    Announcement ↗

Founder

Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond

Investors in Imperagen

Backers from this company's tracked funding rounds.

  • PPXN VenturesLead investorVC firm
  • IIQ CapitalVC firm
  • NNorthern GritstoneVC firm

Imperagen in the news

Coverage of this company's funding, tracked by Datapile.

More DeepTech companies

Recently funded startups in the same category.

Related on Datapile